ISUOG ガイドラインコーナー
- ISUOG Practice Guidelines: performance of third-trimester obstetric ultrasound scanPDF
- Updated ISUOG Practice Guidelines: fetal cardiac screeningPDF
- Updated ISUOG Practice Guidelines: performance of fetal magnetic resonance imagingPDF
- Updated ISUOG Practice Guidelines: Performance of 11-14- week ultrasound scanPDF
- Role of ultrasound in the prediction of spontaneous preterm birthPDF
- Performance of the routine mid-trimester fetal ultrasound scanPDF
- Use of Doppler velocimetry in obstetricsPDF
- Sonographic examination of the fetal central nervous system: part 2PDF
- Sonographic examination of the fetal central nervous system: part 1PDF
- Diagnosis and management of small-for-gestational-age fetus and fetal growth restrictionPDF
- Role of ultrasound in congenital infectionPDF
- Ultrasound assessment of fetal biometry and growthPDF
- Role of ultrasound in screening for and follow-up of pre-eclampsiaPDF
- Intrapartum ultrasoundPDF
- Performance of fetal magnetic resonance imagingPDF
- Invasive procedures for prenatal diagnosisPDF
- Role of ultrasound in twin pregnancyPDF
- Sonographic screening examination of the fetal heartPDF
- International Consensus Statement on use of non-invasive imaging techniques for diagnosis and classification of pelvic deep endometriosisPDF
- ESGO-ISUOG-IOTA-ESGE Consensus Statement on preoperative diagnosis of ovarian tumorsPDF
- ISUOG Consensus Statement on rationalization of early-pregnancy care and provision of ultrasonography in context of SARS-CoV-2PDF
- ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS-CoV-2PDF
- ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in the context of COVID-19PDF
- ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practicePDF
- ISUOG Consensus Statement on current understanding of the association of neurodevelopmental delay and congenital heart diseasePDF
- ISUOG Consensus Statement: Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP) an international consensusPDF
- ISUOG Consensus Statement: Impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practicalPDF
- ISUOG Consensus Statement: What constitutes a fetal echocardiogram?PDF
- Safety Statement on Use of RespiratorsPDF
- ISUOG statement on the safe use of Doppler for fetal ultrasound examination in the first 13+6 weeks of pregnancy (updated)PDF
- ISUOG statement on the non-diagnostic use of ultrasound in pregnancyPDF
- ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasoundPDF
- ISUOG Safety Committee Position Statement: safe performance of obstetric and gynecological scans and equipment cleaning in the context of COVID-19PDF
- Response to JAMA Pediatrics paper on the association of prenatal ultrasonography and autism spectrum disorder by the ISUOG Safety CommitteePDF
- ISUOG statement on ultrasound exposure in the first trimester and autism spectrum disordersPDF
- ISUOG-WFUMB statement on the non-medical use of ultrasound, 2011PDF
- ISUOG statement on the safe use of Doppler in the 11 to 13 + 6-week fetal ultrasound examinationPDF
- ISUOG statement on the non-medical use of ultrasound, 2009PDF
- ISUOG Safety Statement, 2000 (reconfirmed 2003)PDF
- ISUOG Safety Statement, 2000 (reconfirmed 2002)PDF
- ISUOG Safety Statement, 2000PDF
Proposal for ISUOG Guidelines
